drugset
drugset / Trial / NCT01492647

A Study of JNJ 10229570-AAA to Evaluate Safety and Tolerability in Japanese Participants With Acne Vulgaris

NCT01492647 ↗

Phase 1 Completed 18 enrolled Janssen Pharmaceutical K.K.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the safety and tolerability of JNJ 10229570-AAA after a single topical application of JNJ 10229570-AAA 1.2% and 3.6% cream in Japanese participants with acne.

Timeline

Start
2011-08
Primary completion
2011-10
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject JNJ 10229570-AAA Unknown 1.2 % Topical
Subject JNJ 10229570-AAA Unknown 3.6 % Topical

Indications

acne